Vol 4, No 5 (March 11, 2016): Annals of Translational Medicine

Original Article

Immuno-regulated common markers but different network signatures in two associated cancers: evidences from epigenetic treatment
Enrico Capobianco
Annals of Translational Medicine
 2016;
4
(5)
:86
Chest CT abnormalities and quality of life: relationship in adult cystic fibrosis
Aoife Kilcoyne, Lisa P. Lavelle, Colin J. McCarthy, Sinead H. McEvoy, Hannah Fleming, Annika Gallagher, Martine Loeve, Harm Tiddens, Edward McKone, Charles C. Gallagher, Jonathan D. Dodd
Annals of Translational Medicine
 2016;
4
(5)
:87
Analysis of the height dependence of site-specific cancer risk in relation to organ mass
Zi-Wei Lin
Annals of Translational Medicine
 2016;
4
(5)
:88

Review Article

Thoracic surgical training in Europe: what has changed recently?
Lieven P. Depypere, Antoon E. M. R. Lerut
Annals of Translational Medicine
 2016;
4
(5)
:89
Objective and quantitative assessment of motor function in Parkinson’s disease—from the perspective of practical applications
Ke Yang, Wei-Xi Xiong, eng-Tao Liu, Yi-Min Sun, Susan Luo, Zheng-Tong Ding, Jian-Jun Wu, Jian Wang
Annals of Translational Medicine
 2016;
4
(5)
:90

Editorial

Biological samples transportation by drones: ready for prime time?
Giuseppe Lippi, Camilla Mattiuzzi
Annals of Translational Medicine
 2016;
4
(5)
:92
Getting to the core of fibrosis: targeting redox imbalance in aging
Louise Hecker, Victor J. Thannickal
Annals of Translational Medicine
 2016;
4
(5)
:93
Radiotherapy: killing with complement
Jean F. Regal, Kenneth J. Dornfeld, Sherry D. Fleming
Annals of Translational Medicine
 2016;
4
(5)
:94
Combination therapy with TLR7 agonist and radiation is effective for the treatment of solid cancer
Hiroyasu Ito
Annals of Translational Medicine
 2016;
4
(5)
:95
Mutations at the splice sites of exon 14 of MET gene: a new target for sarcomatoid carcinomas?
Marie Wislez, Charlotte Domblides, Alexis Cortot, Antoinette Lemoine
Annals of Translational Medicine
 2016;
4
(5)
:96
Has MET met its match?
Alain Borczuk, Daniel Paucar, Balazs Halmos
Annals of Translational Medicine
 2016;
4
(5)
:97

Perspective

Management of lower pole renal stones: the devil is in the details
Berkan Resorlu, Yasar Issi, Kadir Onem, Cankon Germiyanoglu
Annals of Translational Medicine
 2016;
4
(5)
:98

Commentary

Assessing the cardiovascular risk of hormonal therapy in patients with prostate cancer
Theodoros Karantanos, Styliani Karanika
Annals of Translational Medicine
 2016;
4
(5)
:99
Combination therapy for metastatic renal cell carcinoma
Carlo Buonerba, Giuseppe Di Lorenzo, Guru Sonpavde
Annals of Translational Medicine
 2016;
4
(5)
:100
A novel role of hepatic epithelial transforming growth factor-β signaling in cholangiocarcinogenesis
Man Liu, Myth T. S. Mok, Alfred S. L. Cheng
Annals of Translational Medicine
 2016;
4
(5)
:101

Letter to the Editor

Mining of single nucleotide polymorphisms in the 3' untranslated region of liver cancer-implicated miR-122 target genes
Padmanaban S. Suresh, Thejaswini Venkatesh, Rie Tsutsumi
Annals of Translational Medicine
 2016;
4
(5)
:102

Disclosure:

1. The series “Big-data Clinical Trial Column” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding.